{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T12:13:20Z","timestamp":1761394400849},"reference-count":15,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":660,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aliment Pharmacol Ther"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1111\/apt.12544","type":"journal-article","created":{"date-parts":[[2013,11,11]],"date-time":"2013-11-11T02:50:44Z","timestamp":1384138244000},"page":"85-92","source":"Crossref","is-referenced-by-count":29,"title":["Detection of low HCV viraemia by repeated HCV RNA testing predicts treatment failure to triple therapy with telaprevir"],"prefix":"10.1111","volume":"39","author":[{"given":"B.","family":"Maasoumy","sequence":"first","affiliation":[{"name":"Department of Gastroenterology; Hepatology and Endocrinology; Hannover Medical School; Hannover Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Cobb","sequence":"additional","affiliation":[{"name":"Roche Molecular Systems; Pleasanton CA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"Bremer","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology; Hepatology and Endocrinology; Hannover Medical School; Hannover Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"K.","family":"Luk","sequence":"additional","affiliation":[{"name":"Roche Molecular Systems; Pleasanton CA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Halfon","sequence":"additional","affiliation":[{"name":"Laboratoire ALPHABIO; Hopital Ambroise Pare; Marseille France"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Aslam","sequence":"additional","affiliation":[{"name":"Roche Molecular Systems; Pleasanton CA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. P.","family":"Manns","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology; Hepatology and Endocrinology; Hannover Medical School; Hannover Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Cornberg","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology; Hepatology and Endocrinology; Hannover Medical School; Hannover Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H.","family":"Wedemeyer","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology; Hepatology and Endocrinology; Hannover Medical School; Hannover Germany"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2013,11,10]]},"reference":[{"key":"10.1111\/apt.12544-BIB0001|apt12544-cit-0001","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.jhep.2011.02.023","article-title":"Management of hepatitis C virus infection","volume":"55","author":"EASL Clinical Practice Guidelines","year":"2011","journal-title":"J Hepatol"},{"key":"10.1111\/apt.12544-BIB0002|apt12544-cit-0002","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.bpg.2012.09.009","article-title":"Natural history of acute and chronic hepatitis C","volume":"26","author":"Maasoumy","year":"2012","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1111\/apt.12544-BIB0003|apt12544-cit-0003","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1002\/hep.26141","article-title":"Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to hepatitis C virus seroprevalence","volume":"57","author":"Hanafiah","year":"2012","journal-title":"Hepatology"},{"issue":"Suppl. 1","key":"10.1111\/apt.12544-BIB0004|apt12544-cit-0004","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1016\/S0168-8278(12)60010-5","article-title":"Antiviral strategies in hepatitis C virus infection","volume":"56","author":"Sarrazin","year":"2012","journal-title":"J Hepatol"},{"key":"10.1111\/apt.12544-BIB0005|apt12544-cit-0005","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1136\/gutjnl-2012-302910","article-title":"New protease inhibitors and direct-acting antivirals for hepatitis C: interferon's long goodbye","volume":"61","author":"Dusheiko","year":"2012","journal-title":"Gut"},{"key":"10.1111\/apt.12544-BIB0006|apt12544-cit-0006","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1002\/hep.24641","article-title":"An update on treatment of genotype 1 chronic hepatitis C virus infection: 2011 practice guideline by the American Association for the Study of Liver Diseases","volume":"54","author":"Ghany","year":"2011","journal-title":"Hepatology"},{"key":"10.1111\/apt.12544-BIB0007|apt12544-cit-0007","first-page":"57","article-title":"[Expert opinion on boceprevir- and telaprevir-based triple therapies of chronic hepatitis C]","volume":"50","author":"Sarrazin","year":"2012","journal-title":"Z Gastroenterol"},{"key":"10.1111\/apt.12544-BIB0008|apt12544-cit-0008","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1002\/hep.24791","article-title":"Clinical relevance of detectable but not quantifiable hepatitis C virus RNA during boceprevir or telaprevir treatment","volume":"55","author":"Harrington","year":"2012","journal-title":"Hepatology"},{"issue":"Suppl. 1","key":"10.1111\/apt.12544-BIB0009|apt12544-cit-0009","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1478-3231.2008.01926.x","article-title":"How to use virological tools for optimal management of chronic hepatitis C","volume":"29","author":"Chevaliez","year":"2009","journal-title":"Liver Int"},{"key":"10.1111\/apt.12544-BIB0010|apt12544-cit-0010","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S1665-2681(19)31804-6","article-title":"Virological techniques for the diagnosis and monitoring of hepatitis B and C","volume":"8","author":"Chevaliez","year":"2009","journal-title":"Ann Hepatol"},{"key":"10.1111\/apt.12544-BIB0011|apt12544-cit-0011","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1128\/JCM.01784-12","article-title":"Second-generation Cobas AmpliPrep\/Cobas TaqMan HCV quantitative test for viral load monitoring: a novel dual-probe assay design","volume":"51","author":"Zitzer","year":"2013","journal-title":"J Clin Microbiol"},{"issue":"Suppl.","key":"10.1111\/apt.12544-BIB0012|apt12544-cit-0012","first-page":"676A","article-title":"The ExPECT study: an international multicenter clinical trial evaluating low HCV RNA viremia with the COBAS AmpliPrep\/COBAS TaqMan HCV Test, v2.0 compared to assays used in routine clinical practise and in drug trials","volume":"56","author":"Wedemeyer","year":"2012","journal-title":"Hepatology"},{"key":"10.1111\/apt.12544-BIB0013|apt12544-cit-0013","doi-asserted-by":"crossref","first-page":"e55285","DOI":"10.1371\/journal.pone.0055285","article-title":"Eligibility and safety of triple therapy for hepatitis C: lessons learned from the first experience in a real world setting","volume":"8","author":"Maasoumy","year":"2013","journal-title":"PLoS ONE"},{"key":"10.1111\/apt.12544-BIB0014|apt12544-cit-0014","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/j.jhep.2013.04.035","article-title":"Triple therapy in treatment-experienced patients with hcv-cirrhosis in a multicentre cohort of the french early access programme (anrs co20-cupic) - nct01514890","volume":"59","author":"Hezode","year":"2013","journal-title":"J Hepatol"},{"issue":"Suppl.","key":"10.1111\/apt.12544-BIB0015|apt12544-cit-0015","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0168-8278(13)60508-5","article-title":"Undetectable HCV-RNA in telaprevir-treated patients: low concordance between two highly sensitive real-time pcr assays","volume":"58","author":"Vermehren","year":"2013","journal-title":"J Hepatol"}],"container-title":["Alimentary Pharmacology & Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fapt.12544","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1111\/apt.12544\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,4]],"date-time":"2021-07-04T17:11:33Z","timestamp":1625418693000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/apt.12544"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11,10]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"URL":"https:\/\/doi.org\/10.1111\/apt.12544","relation":{},"ISSN":["0269-2813"],"issn-type":[{"value":"0269-2813","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11,10]]}}}